Application of arginase-1 and glypican-3 combined examination in differential diagnosis of hepatocellular carcinoma

被引：0
|
作者：
顾春燕 [1 ]
机构：
[1] Dept Pathol,Affil Nantong 3rd Hosp,Nantong Univ
来源：
China Medical Abstracts(Internal Medicine) | 2014年 / 31卷 / 03期
关键词：
HCC; GPC; Application of arginase-1 and glypican-3 combined examination in differential diagnosis of hepatocellular carcinoma;
D O I：
暂无
中图分类号：
R735.7 [肝肿瘤];
学科分类号：
100214 ;
摘要：
Objective To explore the value of arginase-1(Arg-1)and glypican-3(GPC-3)combined examination in the differential diagnosis of hepatocellular carcinoma(HCC),metastatic carcinoma(MC)of liver and intrahepatic cholangiocarcinoma(ICC).Methods From January2005 to December 2011,a total of 54 patients with HCC were selected,including 10 cases with high differentiation,25 cases with moderate differentiation and 19 cases with poor differentiation.At the same time,25 patients with MC of liver and 20 patients with ICC were selected.
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [21] Glypican-3 as a serum marker for hepatocellular carcinoma
    Capurro, M
    Filmus, J
    CANCER RESEARCH, 2005, 65 (01) : 372 - 372
  • [22] Value of glypican-3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy
    Anatelli, F.
    Chuang, S. T.
    Yang, X. J.
    Wang, H. L.
    MODERN PATHOLOGY, 2007, 20 : 276A - 276A
  • [23] Upregulation of Glypican-3 in Human Hepatocellular Carcinoma
    Beppu, Tetsuya
    Suzuki, Masahiro
    Sugimoto, Kazushi
    Tanaka, Junnichiro
    Tameda, Masahiko
    Inagaki, Yuji
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Yamamoto, Norihiko
    Uchida, Kazuhiko
    Takase, Koujiro
    Shiraki, Katsuya
    GASTROENTEROLOGY, 2012, 142 (05) : S972 - S972
  • [24] Glypican-3 is overexpressed in human hepatocellular carcinoma
    Sung, YK
    Hwang, SY
    Park, MK
    Farooq, M
    Han, IS
    Bae, HI
    Kim, JC
    Kim, M
    CANCER SCIENCE, 2003, 94 (03): : 259 - 262
  • [25] Epigenetic regulation of glypican-3 in hepatocellular carcinoma
    Trinh, Thu L.
    Puszyk, William
    Liu, Chen
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Evaluation of glypican-3 in patients with hepatocellular carcinoma
    Batbaatar, Batchimeg
    Gurbadam, Unenbat
    Tuvshinsaikhan, Odonchimeg
    Narmandakh, Nyam-Erdene
    Khatanbaatar, Gerelee
    Radnaabazar, Munkhbat
    Erdene-Ochir, Dulguun
    Boldbaatar, Minjuur
    Byambaragchaa, Munkhdelger
    Amankyeldi, Yerbolat
    Chogsom, Munkhzaya
    Ganbileg, Nyamsuren
    Batdelger, Amgalantuul
    Demchig, Tserendorj
    Nyam-Osor, Lkham
    Bayartugs, Batsaikhan
    Batmunkh, Enkhtsatsral
    Munkhjargal, Batkhishig
    Lonjid, Tulgaa
    Khasbagana, Batbayar
    Batmunkh, Munkhbat
    Jav, Sarantuya
    Semchin, Munkhbayar
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (01)
  • [27] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Yao, Min
    Pan, Liu-Hong
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 122 - 123
  • [28] Glypican-3 as a specific biomarker for hepatocellular carcinoma
    Min Yao
    Liu-Hong Pan
    Deng-Fu Yao
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 122 - 123
  • [29] Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: A tissue microarray-based study
    Zhang, Lijie
    Liu, Hui
    Sun, Lin
    Li, Ning
    Ding, Huiguo
    Zheng, Jie
    ACTA HISTOCHEMICA, 2012, 114 (06) : 547 - 552
  • [30] Arginase-1, HepPar-1, and Glypican-3 Are the Most Effective Panel of Markers in Distinguishing Hepatocellular Carcinoma From Metastatic Tumor on Fine-Needle Aspiration Specimens
    Timek, Dana T.
    Shi, Jianhui
    Liu, Haiyan
    Lin, Fan
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (02) : 203 - 210
12345